세계의 바이오테크놀러지 시장 규모, 점유율, 성장 분석 : 제품 유형별, 기술별, 용도별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)
Biotechnology Market Size, Share, and Growth Analysis, By Product Type (Instruments, Reagents), By Technology (Nano Biotechnology, PCR Technology), By Application, By End User, By Region - Industry Forecast 2025-2032
상품코드:1701450
리서치사:SkyQuest
발행일:2025년 04월
페이지 정보:영문 260 Pages
라이선스 & 가격 (부가세 별도)
한글목차
바이오테크놀러지 시장 규모는 2023년 2조 1,200억 달러, 2024년 2조 3,900억 달러에서 2032년 6조 2,600억 달러로 성장하고, 예측 기간(2025-2032년) 동안 12.79%의 연평균 복합 성장률(CAGR)을 보일 것으로 예측됩니다.
바이오테크놀러지 산업은 고도로 세계화된 분야로 국가 간 다양한 경제 성장을 경험하고 있습니다. 건강 문제, 특히 B형 간염, 당뇨병, 암과 같은 만성 질환 증가는 바이오테크놀러지 솔루션에 대한 수요를 촉진할 것으로 예측됩니다. 미국, 중국, 인도 등 주요 국가의 인구가 증가함에 따라 밀, 쌀, 사탕수수 등 농산물 수요도 증가할 것으로 보입니다. 동시에 과학자들은 물 부족, 낮은 수확량, 해충의 위협과 같은 문제를 완화하기 위해 스마트 농업 시스템에 초점을 맞춘 연구개발에 적극 나서고 있습니다. 정부 기관 및 독립적인 기업과의 협력을 통해 연구개발을 위한 자금이 강화되고, 바이오테크놀러지의 혁신을 촉진하고 있습니다. 그 결과, 이 분야의 기업들, 특히 효과적인 치료법 개발에 전념하는 기업들은 큰 기회를 얻을 수 있는 준비가 되어 있습니다.
목차
서론
조사 목적
조사 범위
정의
조사 방법
정보 조달
2차와 1차 데이터 방법
시장 규모 예측
시장 전제조건과 제한
주요 요약
세계 시장 전망
공급과 수요 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
성장 촉진요인과 기회
성장 억제요인과 과제
Porter의 Five Forces 분석
주요 시장 인사이트
중요 성공 요인
경쟁 정도
주요 투자 기회
시장 생태계
시장의 매력 지수(2024년)
PESTEL 분석
거시경제 지표
밸류체인 분석
가격 분석
규제 상황
사례 연구
기술 분석
바이오테크놀러지 시장 규모 : 제품 유형별
시장 개요
기기
시약
서비스
소프트웨어
바이오테크놀러지 시장 규모 : 기술별
시장 개요
나노 바이오테크놀러지
PCR 기술
DNA 시퀀싱
크로마토그래피
조직공학 및 재생
세포 기반 어세이
발효
기타
바이오테크놀러지 시장 규모 : 용도별
시장 개요
바이오 파머시
바이오 산업
바이오 서비스
바이오 인포매틱스
바이오 농업
바이오테크놀러지 시장 규모 : 최종사용자별
시장 개요
제약회사 및 바이오테크놀러지 기업
계약연구기관
학술연구기관
기타
바이오테크놀러지 시장 규모
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카
중동 및 아프리카
GCC 국가
남아프리카공화국
기타 중동 및 아프리카
경쟁 정보
주요 5개사 비교
주요 기업의 시장 포지셔닝(2024년)
주요 시장 기업이 채택한 전략
최근 시장 동향
기업의 시장 점유율 분석(2024년)
주요 기업 개요
기업 상세
제품 포트폴리오 분석
기업 부문별 점유율 분석
매출 전년대비 비교(2022-2024년)
주요 기업 개요
Amgen Inc.(USA)
Gilead Sciences, Inc.(USA)
Genentech(Roche)(Switzerland)
Biogen Inc.(USA)
Regeneron Pharmaceuticals, Inc.(USA)
Moderna, Inc.(USA)
Illumina, Inc.(USA)
Vertex Pharmaceuticals(USA)
AbbVie Inc.(USA)
Eli Lilly and Company(USA)
Sanofi S.A.(France)
Novozymes(Denmark)
CSL Limited(Australia)
Celgene Corporation(USA)
Bristol-Myers Squibb Company(USA)
Novo Nordisk(Denmark)
AstraZeneca PLC(UK/Sweden)
Stryker Corporation(USA)
Merck & Co., Inc.(USA)
Johnson & Johnson(USA)
결론과 제안
LSH
영문 목차
영문목차
Biotechnology Market size was valued at USD 2.12 trillion in 2023 and is poised to grow from USD 2.39 trillion in 2024 to USD 6.26 trillion by 2032, growing at a CAGR of 12.79% during the forecast period (2025-2032).
The biotech industry is a highly globalized sector experiencing diverse economic growth across nations. Rising health issues, particularly hepatitis B and chronic diseases like diabetes and cancer, are anticipated to drive demand for biotech solutions. The increasing populations in major countries such as the US, China, and India will also heighten the need for agricultural products, including wheat, rice, and sugarcane. Concurrently, scientists are actively engaged in R&D to mitigate challenges such as water scarcity, low crop yield, and pest threats, focusing on smart agricultural systems. Collaborative efforts with both governmental and independent entities are boosting funding for research and development, fostering innovations in biotechnology. Consequently, companies in this field are poised for significant opportunities, particularly those dedicated to developing effective treatments.
Top-down and bottom-up approaches were used to estimate and validate the size of the Biotechnology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Biotechnology Market Segments Analysis
Global Biotechnology Market is segmented by Product Type, Technology, Application, End User and region. Based on Product Type, the market is segmented into Instruments, Reagents, Services and Software. Based on Technology, the market is segmented into Nano Biotechnology, PCR Technology,DNA sequencing, Chromatography, Tissue Engineering and Regeneration, Cell-Based Assays, Fermentation and Others. Based on Application, the market is segmented into Bio-pharmacy, Bio-industrial, Bio-services, Bioinformatics and Bio-agriculture. Based on End User, the market is segmented into Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Biotechnology Market
The global biotechnology market is being significantly driven by the rising incidence of chronic diseases, including cancer and diabetes. As the prevalence of these health issues escalates worldwide, there is a correspondingly growing demand for effective treatments. This urgent need for innovative therapeutic solutions is propelling the expansion of the biotechnology sector on a global scale. The increasing focus on research and development in biotechnology to address these pressing health concerns is further enhancing market growth. As a result, the biotechnology industry is poised for continuous advancement and investment, driven by the imperative to combat chronic illnesses effectively.
Restraints in the Biotechnology Market
The biotechnology sector is heavily reliant on innovation, and when one company secures a patent by being the first to develop a new technology, it can create significant delays for competing firms seeking to bring similar products to market. This situation arises because competitors are unable to use patented methods without facing legal challenges, leading to potential conflicts over intellectual property rights. Such patent-related issues and overlaps can act as considerable barriers to market growth, as they restrict the ability of other companies to leverage similar technologies and diminish their competitive edge in bringing innovative solutions to consumers.
Market Trends of the Biotechnology Market
The biotechnology market is witnessing a significant trend towards synthetic biology, a rapidly growing segment poised to revolutionize various industries including pharmaceuticals, agriculture, and biofuels. This innovative approach enables companies to design and engineer biological systems for diverse applications, enhancing efficiency and sustainability. As the demand for eco-friendly solutions escalates, biotechnology firms are increasingly investing in synthetic biology to develop novel products and processes that address global challenges such as climate change and health crises. By leveraging advances in genetic engineering and computational biology, these companies are not only maximizing revenue opportunities but also positioning themselves as leaders in the future of biotechnological advancements.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technology Analysis
Global Biotechnology Market Size by Product Type & CAGR (2025-2032)
Market Overview
Instruments
Reagents
Services
Software
Global Biotechnology Market Size by Technology & CAGR (2025-2032)
Market Overview
Nano Biotechnology
PCR Technology
DNA Sequencing
Chromatography
Tissue Engineering and Regeneration
Cell-Based Assays
Fermentation
Others
Global Biotechnology Market Size by Application & CAGR (2025-2032)
Market Overview
Bio-pharmacy
Bio-industrial
Bio-services
Bioinformatics
Bio-agriculture
Global Biotechnology Market Size by End User & CAGR (2025-2032)
Market Overview
Pharmaceutical and Biotechnology Companies
Contract Research Organizations
Academic and Research Institutes
Others
Global Biotechnology Market Size & CAGR (2025-2032)
North America (Product Type, Technology, Application, End User)
US
Canada
Europe (Product Type, Technology, Application, End User)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Product Type, Technology, Application, End User)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Product Type, Technology, Application, End User)
Brazil
Rest of Latin America
Middle East & Africa (Product Type, Technology, Application, End User)